Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation

Resuscitation

Volumn 76, Issue 1, 2008, Pages 89-94

  Hutchens, Michael P ^a   Nakano, Takaaki ^a   Dunlap, Jennifer ^a   Traystman, Richard J ^a   Hurn, Patricia D ^a   Alkayed, Nabil J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood pressure; Cardiac arrest; CPR; EPHX2; Epoxyeicosatrienoic acids; Ischemia; P450 epoxygenase; Soluble epoxide hydrolase

Indexed keywords

CYTOCHROME P450 ARACHIDONIC ACID EPOXYGENASE; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; OXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; C57BL 6 MOUSE; CONTROLLED STUDY; CONVALESCENCE; DISEASE MODEL; ENZYME ACTIVITY; GENE; GENE DELETION; HEART ARREST; HEART MUSCLE ISCHEMIA; HYPERTENSION; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; RESUSCITATION; SEH GENE; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; CARDIOPULMONARY RESUSCITATION; ELECTROCARDIOGRAPHY; EPOXIDE HYDROLASES; GENE DELETION; HEART ARREST; MICE; MICE, INBRED C57BL; SURVIVAL RATE;

EID: 36849019028     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2007.06.031     Document Type: Article

References (27)

1. Liu M., Hurn P.D., and Alkayed N.J. Cytochrome P450 in neurological disease. Curr Drug Metab 5 (2004) 225-234
2. Campbell W.B., Gebremedhin D., Pratt P.F., and Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78 (1996) 415-423
3. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276 (2001) 36059-36062
4. Zhao X., Yamamoto T., Newman J.W., et al. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J Am Soc Nephrol 15 (2004) 1244-1253
5. Dorrance A.M., Rupp N., Pollock D.M., Newman J.W., Hammock B.D., and Imig J.D. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 46 (2005) 842-848
6. Zhang W, Koerner IP, Noppens R, et al. Soluble epoxide hydrolase: a novel therapeutic target in stroke. J Cereb Blood Flow Metab 2007 April 18; [Epub ahead of print].
7. Sinal C.J., Miyata M., Tohkin M., Nagata K., Bend J.R., and Gonzalez F.J. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275 (2000) 40504-40510
8. Seubert J.M., Sinal C.J., Graves J., et al. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99 (2006) 442-450
9. Rosamond W.D., Chambless L.E., Folsom A.R., et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987-1994. N Engl J Med 339 (1998) 861-867
10. Burne-Taney M.J., Kofler J., Yokota N., Weisfeldt M., Traystman R.J., and Rabb H. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 285 (2003) F87-F94
11. Traystman R.J. Animal models of focal and global cerebral ischemia. ILAR J 44 (2003) 85-95
12. Kofler J., Hattori K., Sawada M., et al. Histopathological and behavioral characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice. J Neurosci Methods 136 (2004) 33-44
13. Noppens R.R., Kofler J., Hurn P.D., and Traystman R.J. Dose-dependent neuroprotection by 17beta-estradiol after cardiac arrest and cardiopulmonary resuscitation. Crit Care Med 33 (2005) 1595-1602
14. Kofler J., Hurn P.D., and Traystman R.J. SOD1 overexpression and female sex exhibit region-specific neuroprotection after global cerebral ischemia due to cardiac arrest. J Cereb Blood Flow Metab 25 (2005) 1130-1137
15. Kofler J., Otsuka T., Zhang Z., et al. Differential effect of PARP-2 deletion on brain injury after focal and global cerebral ischemia. J Cereb Blood Flow Metab 26 (2006) 135-141
16. Imig J.D., Zhao X., Zaharis C.Z., et al. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46 (2005) 975-981
17. Pratt P.F., Medhora M., and Harder D.R. Mechanisms regulating cerebral blood flow as therapeutic targets. Curr Opin Investig Drugs 5 (2004) 952-956
18. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285 (1999) 1276-1279
19. Krotz F., Riexinger T., Buerkle M.A., et al. Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. Arterioscler Thromb Vasc Biol 24 (2004) 595-600
20. Chen J.K., Capdevila J., and Harris R.C. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 21 (2001) 6322-6331
21. Seubert J., Yang B., Bradbury J.A., et al. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res 95 (2004) 506-514
22. Koerner I.P., Jacks R., DeBarber A.E., et al. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury. J Neurosci 27 17 (2007) 4642-4649
23. Ellis E.F., Police R.J., Yancey L., McKinney J.S., and Amruthesh S.C. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 259 (1990) H1171-H1177
24. Christman C.W., Wei E.P., Kontos H.A., Povlishock J.T., and Ellis E.F. Effects of 15-hydroperoxy-eicosatetraenoic acid (15-HPETE) on cerebral arterioles of cats. Am J Physiol 247 (1984) H631-H637
25. Larsen B.T., Miura H., Hatoum O.A., et al. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(ca) channels: implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 290 (2006) H491-H499
26. Luria A., Weldon S.M., Kabcenell A.K., et al. Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice. J Biol Chem 282 (2007) 2891-2898
27. Pokreisz P., Fleming I., Kiss L., et al. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 47 (2006) 762-770